跳至主要内容
临床试验/NCT01287507
NCT01287507已完成不适用

Oral Lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T-regulatory Cells.

Ankara University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Necrotising enterocolitis

研究概览

简要总结

The aim of the study is to evaluate whether oral administration of 200 mg/day lactoferrin (LF) to very low birth weight infants reduces late onset sepsis and necrotising enterocolitis and the effect of LF on regulatory T cells.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Care Provider)

入排标准

年龄范围
15 Minutes 至 1 Day(Child)
性别
All
接受健康志愿者

入选标准

  • Inborn infants
  • Gestational age < 32 weeks
  • Birth weight < 1500 g
  • Parental consent

排除标准

  • Congenital abnormalities
  • Severe perinatal asphyxia

结局指标

主要结局

Necrotising enterocolitis

时间窗: from birth to discharge from NICU

The effect of oral Lactoferrin prophylaxis on severe necrotising enterocolitis (NEC) (Bell's stage 2 and 3) in very low birth infants during the hospitalization period in Neonatal intensive care unit. In case of feeding intolerance, abdominal distention and findings of ileus with clinical deterioration, patient will be evaluated for thrombocytopenia, metabolic acidosis, hyponatremia, blood in stool and radiological findings of NEC. Staging will be performed with clinical, laboratory and radiological findings.

late onset sepsis

时间窗: from birth to discharge from NICU

The effect of oral Lactoferrin prophylaxis on the number of culture proven sepsis attacks in very low birth weight infants during their hospitalization in neonatal intensive care unit. Sterile blood, urine and cerebrospinal fluid samples will be obtained in case of clinical symptoms of sepsis for culture.

Effect on T regulatory cells

时间窗: at discharge

FOXP3 expression on CD4+CD25+ T cells

次要结局

  • Safety of lactoferrin in VLBW infants(during the oral use of lactoferrin)
  • duration of hospitalization(from birth to discharge from neonatal intensive care unit)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ilke Mungan Akin

Neonatologist

Ankara University

研究点 (2)

Loading locations...

相似试验